𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Milestones in clinical neurophysiology

✍ Scribed by Mark Hallett; John Rothwell


Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
322 KB
Volume
26
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Over the last 25 years, clinical neurophysiology has made many advances in the understanding, diagnosis, and even treatment of different movement disorders. Transcranial magnetic stimulation has been the biggest technical advance. Progress in pathophysiology includes improved knowledge about bradykinesia in Parkinson's disease, loss of inhibition and increased plasticity in dystonia, abnormal startle in hyperekplexia, and various features of psychogenic movement disorders that can aid diagnosis. Studies have been done looking at the use of noninvasive brain stimulation for therapy, but effects are generally small. Β© 2011 Movement Disorder Society


πŸ“œ SIMILAR VOLUMES


Clinical neurophysiology education in re
✍ MD Stuart A. Schneck πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 230 KB

In the interest of improving our specialty of neurology, consider the following assertions: (1) Three years of residency training are no longer sufficient to teach and assimilate all the neurological knowledge and clinical skills needed by a modern neurologist. ( ) Too many clinical neurophysiologic

Laryngeal neurophysiology and its clinic
✍ Gayle E. Woodson πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 971 KB

## Companion papers in this and the subsequent issue of Head & Neck will provide the clinician with up-to-date information on the pathophysiology of disturbances of laryngeal function and current methods of vocal fold medialization through applications of contemporary techniques of laryngeal framew

Milestones in Parkinson's diseaseβ€”Clinic
✍ Glenda Halliday; Andrew Lees; Matthew Stern πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 350 KB πŸ‘ 1 views

## Abstract The identification of the widespread deposition of fibrillized α‐synuclein in Lewy bodies and Lewy neurites in the brains of patients with Parkinson's disease in 1997 has had a profound impact on how the disease is now conceptualized. The previous focus on the loss of the dopaminergic n